Results 41 to 50 of about 19,638 (219)

“It's the Exact Same Treatment … Except Only 5 Min Away”: A RE‐AIM Evaluation of a Speech‐Language Pathology Shared‐Care Model for Rural Patients With Head and Neck Cancer

Head &Neck, EarlyView.
ABSTRACT Background Challenges accessing post‐treatment speech‐language pathology (SLP) services can add to treatment burden for rural patients with head and neck cancer (HNC). Hence, the aim of this study was to evaluate a shared‐care SLP service designed to support local SLP access for patients with HNC, using the RE‐AIM framework.
Corey Patterson, Elizabeth C. Ward, Rebecca L. Packer, Jasmine Foley, Laurelie R. Wishart, Clare L. Burns, Sally Pether, Wendy Comben   +7 more
wiley   +1 more source

A 3D surface coil with deep learning‐based noise reduction for parotid gland imaging at 7T

iRADIOLOGY
Background Background: Parotid gland neoplasms occur near the facial nerve. Hence, it is crucial to determine whether the malignant neoplasms involve the facial nerve and whether sacrifice of the nerve in surgery is necessary.
Sayim Gokyar, Chenyang Zhao, Shajan Gunamony, Liyang Tang, Jonathan West, Niels Kokot, Danny J. J. Wang   +6 more
doaj   +1 more source

Clinicogenomic Features and Outcomes of Adenoid Cystic Carcinoma With Central Nervous System Metastases: A Single‐Institution Cohort Study

Head &Neck, EarlyView.
ABSTRACT Background Adenoid cystic carcinoma (ACC) is a rare malignancy with a propensity for perineural invasion and hematogenous spread. Central nervous system (CNS) involvement is uncommon, and detailed clinical and genomic data on this aspect of the disease remain limited.
Omar Elghawy, Jack Stylli, Martin Kurian, Eitan Halper‐Stromberg, Aditi Singh, Christopher D'Avella, Lee Hartner, Roger B. Cohen   +7 more
wiley   +1 more source

Primary Malignant Parotid Lymphoma: Two Case Reports with Different Disease Progression and Treatment

Philippine Journal of Otolaryngology Head and Neck Surgery, 2011
Objective: To describe our experience in managing two cases of primary malignant parotid lymphoma.   Methods: Design: Case Report Setting: Tertiary University Referral Center Patients: Two   Results: Both patients underwent ...
Noor Dina Hashim, Mohd Razif Mohamad Yunus, Asma Abdullah, Marina Mat Baki, Salina Husain, Mazita Ami   +5 more
doaj   +1 more source

A Rare Case of Lymphoepithelial Carcinoma of Salivary Gland in a Patient of Indian Origin [PDF]

National Journal of Laboratory Medicine, 2015
Salivary gland neoplasms comprise 3% of all the head and neck neoplasms. Lymphoepithelial carcinoma of the salivary gland is extremely rare and accounts for less than 1% of all salivary gland neoplasms.
Hemalatha A. L, Sharathkumar H.K, Neelima P Chamarthy, Kunal Puri, Rakhi B   +4 more
doaj   +1 more source

Stereotactic Body Radiotherapy (SBRT) of Previously Unirradiated Mucosal Head and Neck Squamous Cell Carcinoma (SCC)

Head &Neck, EarlyView.
ABSTRACT Purpose To evaluate the efficacy and safety of stereotactic body radiation therapy (SBRT) in previously untreated primary mucosal head and neck cancer (HNC) patients unfit for conventional radiation therapy. Materials and Methods Retrospective analysis of previously unirradiated primary SCC mucosal HNC patients treated with SBRT from 2011 to ...
Mohammed Aldohan, Irene Karam, Amir H. Safavi, Lee Chin, Liying Zhang, Ethan Gooanratne, Madette Galapin, Antoine Eskander, Kevin Higgins, Danny Enepekides, Ian Poon   +10 more
wiley   +1 more source

Myoepithelioma of the Parotid Gland: A Case Report with Review of the Literature and Classic Histopathology

Case Reports in Otolaryngology, 2017
Myoepithelioma is a rare salivary gland neoplasm. They most commonly affect the major and minor salivary glands with the parotid gland being the most common, approximately 40%. Only 1% of all salivary gland neoplasms are myoepitheliomas.
Mark Weitzel, Jason E. Cohn, Harvey Spector   +2 more
doaj   +1 more source

Botulinum Toxin for First Bite Syndrome: A Symptom‐Guided “Follow‐The‐Pain” Injection Strategy

Head &Neck, EarlyView.
ABSTRACT Background To evaluate botulinum toxin type A (BoNT‐A) for First Bite Syndrome (FBS) and assess a symptom‐guided “Follow‐the‐Pain” (FTP) injection strategy in patients with incomplete response to standard treatment. Methods Consecutive patients with postoperative FBS were treated with ultrasound‐guided intraparotid BoNT‐A injection.
Rosario Marchese‐Ragona, Gianmarco Giunta, Daniela Adamo, Elisabetta Zanoletti, Daniele Manfredini, Domenico Antonio Restivo   +5 more
wiley   +1 more source

Synchronous sebaceous lymphadenoma with squamous cell carcinoma – case report

World Journal of Surgical Oncology, 2003
Background Sebaceous lymphadenoma is a rare benign salivary gland tumour of uncertain histogenesis. So is synchronous occurrence of two benign or malignant neoplasms.
Panicker Sathibai, Shukla Mridula
doaj  

Early Postoperative Adverse Events (≤ 30 Days) in Spinal Oncology: Defining the Incidence, Severity, and Predictors in a Mixed Prospective Cohort Including Intradural and Metastatic Spinal Tumors

International Journal of Cancer, EarlyView.
ABSTRACT Complication reporting in spinal tumor surgery remains inconsistently defined. We aimed to quantify the incidence, severity, and spectrum of early (≤ 30 days) postoperative adverse events (AEs) in spinal tumor surgery and to identify predictors of overall and serious complications using standardized severity grading.
Meltem Ivren, Philip Dao Trong, Maximilian Klass, Martin Dugas, Sebastian Ille, Sandro M. Krieg, Pavlina Lenga   +6 more
wiley   +1 more source